• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    56 Biggest Movers From Friday

    1/10/22 4:47:25 AM ET
    $AACG
    $ABSI
    $ACY
    $AEHR
    Other Consumer Services
    Real Estate
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $AACG alert in real time by email

    Gainers

    • Hour Loop, Inc. (NASDAQ:HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share.
    • China HGS Real Estate Inc. (NASDAQ:HGSH) shares surged 57.5% to close at $3.48 on Friday. Traders may be viewing this stock as a play on a Friday deal by Papa John's to expand its presence in China by 1,350 stores. The Papa John's press release did not specifically mention a real estate company it would be working with for the expansion.
    • ATA Creativity Global (NASDAQ:AACG) gained 33.3% to settle at $2.64.
    • Marin Software Incorporated (NASDAQ:MRIN) shares jumped 31.3% to close at $4.53 on Friday after the company announced an integration with Amazon Ads' demand-side platform.
    • Xinyuan Real Estate Co., Ltd. (NYSE:XIN) jumped 25.4% to close at $0.76 in sympathy with China HGS Real Estate following Papa John's Deal for 1.35k new stores in China. However, Papa John's did not specify which/if co. would be working with real estate companies.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) gained 24.2% to settle at $8.06 following an interview by CEO Richard Branson on CNBC.
    • China Natural Resources, Inc. (NASDAQ:CHNR) rose 23.3% to close at $1.06.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) gained 20.3% to close at $3.85.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) surged 19.5% to settle at $2.08 after Maxin Group initiated coverage on the stock with a Buy rating and a $5 price target.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) shares jumped 18.6% to close at $4.97.
    • Innovid Corp. (NYSE:CTV) gained 17.5% to settle at $6.58. JMP Securities recently initiated coverage on Innovid with a Market Outperform rating and announced a price target of $11.
    • Absci Corporation (NASDAQ:ABSI) rose 17.1% to close at $7.19 after the company announced a research collaboration with Merck.
    • Pintec Technology Holdings Limited (NASDAQ:PT) gained 17.1% to settle at $0.4940.
    • Discovery, Inc. (NASDAQ:DISCA) surged 16.9% to settle at $30.06 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $34 to $45.
    • GreenBox POS (NASDAQ:GBOX) rose 15.9% to close at $5.02. GreenBox POS announced acceleration of stock repurchase program.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) jumped 15.6% to close at $0.96.
    • Pharvaris N.V. (NASDAQ:PHVS) gained 15.5% to close at $19.30.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) jumped 15.4% to settle at $2.25.
    • Assertio Holdings, Inc. (NASDAQ:ASRT) climbed 12.5% to close at $2.71.
    • Oxbridge Re Holdings Limited (NASDAQ:OXBR) gained 12.2% to settle at $5.72.
    • Franklin Covey Co. (NYSE:FC) jumped 10.8% to close at $50.66 following Q1 results.
    • Tuya Inc. (NYSE:TUYA) gained 10.6% to close at $5.44.
    • Singular Genomics Systems, Inc. (NASDAQ:OMIC) gained 9.9% to settle at $9.56. B of A Securities upgraded Singular Genomics Systems from Neutral to Buy and announced a $21 price target.
    • Nerdy, Inc. (NYSE:NRDY) gained 8.8% to settle at $4.33. Goldman Sachs initiated coverage on Nerdy with a Buy rating and announced a price target of $8.
    • Simulations Plus, Inc. (NASDAQ:SLP) climbed 8.7% to close at $49.86 following upbeat quarterly sales.
    • GameStop Corp. (NYSE:GME) gained 7.3% to close at $140.62. GameStop is launching a division to develop an NFT marketplace and launch cryptocurrency partnerships, according to a Wall Street Journal report.
    • Personalis, Inc. (NASDAQ:PSNL) gained 7.3% to settle at $12.92. Personalis said it sees Q4 sales of $20.7 million and FY21 sales of $85.5 million.
    • WISeKey International Holding AG (NASDAQ:WKEY) rose 5.6% to close at $4.33 after the company announced plans to generate the first ever NFT from space following the launch of WISeSat on SpaceX Transporter 3 Rideshare mission riding aboard of a Falcon 9 on January 13.
    • OneSmart International Education Group Limited (NYSE:ONE) gained 5.5% to close at $0.2901 after dipping more than 31% on Thursday.


    Check out these big penny stock gainers and losers

    Losers

    • Siyata Mobile Inc. (NASDAQ:SYTA) shares dropped 42.1% to close at $50.66 on Friday after the company announced pricing of a $20 million underwritten public offering.
    • Dave Inc. (NASDAQ:DAVE) fell 31.8% to close at $5.82. Dave and VPC Impact Acquisition Holdings III, Inc. announced closing of business combination.
    • Aehr Test Systems (NASDAQ:AEHR) dropped 21.4% to close at $16.09 after reporting Q2 results.
    • Nuverra Environmental Solutions, Inc. (NYSE:NES) dipped 20.5% to close at $2.25.
    • Kura Sushi USA, Inc. (NASDAQ:KRUS) dipped 20.5% to close at $55.68 after reporting downbeat quarterly sales.
    • Odonate Therapeutics, Inc. (NASDAQ:ODT) dropped 16.8% to settle at $1.09 after the company received notice from The Nasdaq Stock Market that the continued listing of its securities is no longer warranted.
    • Mercurity Fintech Holding Inc. (NASDAQ:MFH) dropped 16.2% to settle at $2.74. The company recently posted Q3 results.
    • AeroCentury Corp. (NYSE:ACY) declined 16.2% to settle at $47.99. AeroCentury, last month, reported a 5-for-1 split.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) fell 16% to settle at $3.99.
    • Local Bounti Corporation (NYSE:LOCL) dropped 15.8% to close at $5.05.
    • Dragon Victory International Limited (NASDAQ:LYL) dipped 15.3% to close at $1.16.
    • Aligos Therapeutics, Inc. (NASDAQ:ALGS) fell 14.8% to close at $3.91. JP Morgan downgraded Aligos Therapeutics from Overweight to Neutral and lowered the price target from $30 to $12.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) dropped 14.5% to close at $3.00. PetVivo Holdings, Inc. recently reported distribution of its veterinary medical device, SPRYNG, by Vetcove, Inc.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) dipped 14.1% to settle at $1.04. Avalo Therapeutics recently reported Phase 1b results for AVTX-002 in moderate to severe Crohn's disease patients and presented additional program updates at the 2022 investor event.
    • GH Research PLC (NASDAQ:GHRS) fell 14.1% to settle at $18.68.
    • Privia Health Group, Inc. (NASDAQ:PRVA) dropped 13.5% to close at $22.52. Privia Health Group appointed Jeffrey S. Sherman as CFO.
    • Phunware, Inc. (NASDAQ:PHUN) dipped 13.4% to close at $2.66.
    • Heliogen, Inc. (NYSE:HLGN) fell 12.1% to close at $6.93.
    • AppTech Payments Corp. (NASDAQ:APCX) fell 12% to settle at $2.20 after gaining 8% on Thursday.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) fell 11.8% to close at $16.09. DBGI said it sees Q4 revenue in line with prior forecast of $4 million. The company also expects fiscal year 2021 net revenue to increase 44% to $7.6 million.
    • The New York Times Company (NYSE:NYT) fell 10.7% to close at $42.71 after the company announced it will acquire The Athletic for $550 million.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) dipped 10.4% to close at $53.98. A Thursday afternoon Reuters report suggested Digital World special purpose acquisition corporation (SPAC) merger partner, Trump Media Group, could launch its social media app in February.
    • Sunlight Financial Holdings Inc. (NYSE:SUNL) fell 9.8% to close at $3.88.
    • Zhangmen Education Inc. (NYSE:ZME) shares fell 9.7% to close at $2.1496.
    • Cytokinetics, Incorporated (NASDAQ:CYTK) fell 9.4% to close at $3.91. Cytokinetics and Royalty Pharma report funding deals for total of up to $450 million.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) fell 9.1% to close at $1.20. Plus Therapeutics recently entered into an agreement with UT Health San Antonio for a worldwide exclusive license to develop and commercialize novel interventional therapeutics for cancer.
    • Alterity Therapeutics Limited (NASDAQ:ATHE) shares fell 9% to close at $1.01. Alterity Therapeutics shares jumped around 34% on Thursday after the company announced it was granted a new US patent for "Compounds for and Methods of Treating Diseases."
    Get the next $AACG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AACG
    $ABSI
    $ACY
    $AEHR

    CompanyDatePrice TargetRatingAnalyst
    New York Times Company
    $NYT
    4/22/2026$84.00Neutral
    BofA Securities
    Cytokinetics Incorporated
    $CYTK
    4/10/2026$95.00Overweight
    Wells Fargo
    Pharvaris N.V.
    $PHVS
    4/9/2026$42.00Outperform
    Wolfe Research
    Avalo Therapeutics Inc.
    $AVTX
    4/9/2026$48.00Outperform
    Wolfe Research
    Assertio Holdings Inc.
    $ASRT
    4/9/2026$18.00Buy → Neutral
    H.C. Wainwright
    Aehr Test Systems
    $AEHR
    4/8/2026$68.00Hold → Buy
    Craig Hallum
    Avalo Therapeutics Inc.
    $AVTX
    4/6/2026$52.00Mkt Outperform
    Citizens
    Aligos Therapeutics Inc.
    $ALGS
    3/19/2026$48.00Buy
    Jefferies
    More analyst ratings

    $AACG
    $ABSI
    $ACY
    $AEHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Schikan Johannes Gerardus Christiaan Petrus sold $213,382 worth of shares (7,100 units at $30.05) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 388,067 units (SEC Form 4)

    4 - Pharvaris N.V. (0001830487) (Issuer)

    4/24/26 2:09:35 PM ET
    $PHVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Early Development Lesage Anne exercised 7,600 shares at a strike of $7.62 and sold $441,726 worth of shares (14,700 units at $30.05) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Pharvaris N.V. (0001830487) (Issuer)

    4/24/26 12:18:10 PM ET
    $PHVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Lu Peng exercised 7,101 shares at a strike of $2.59 and sold $213,405 worth of shares (7,101 units at $30.05) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Pharvaris N.V. (0001830487) (Issuer)

    4/24/26 11:27:11 AM ET
    $PHVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AACG
    $ABSI
    $ACY
    $AEHR
    SEC Filings

    View All

    New York Times Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - NEW YORK TIMES CO (0000071691) (Filer)

    4/23/26 5:05:09 PM ET
    $NYT
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form DEFA14A filed by Local Bounti Corporation

    DEFA14A - Local Bounti Corporation/DE (0001840780) (Filer)

    4/23/26 4:16:45 PM ET
    $LOCL
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form DEF 14A filed by Local Bounti Corporation

    DEF 14A - Local Bounti Corporation/DE (0001840780) (Filer)

    4/23/26 4:16:06 PM ET
    $LOCL
    Farming/Seeds/Milling
    Consumer Staples

    $AACG
    $ABSI
    $ACY
    $AEHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Innovation Officer Busch Andreas bought $229,000 worth of shares (100,000 units at $2.29), increasing direct ownership by 31% to 421,446 units (SEC Form 4)

    4 - Absci Corp (0001672688) (Issuer)

    3/16/26 4:17:22 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Large owner A.L. Sarroff Fund, Llc bought 1,250,000 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    3/13/26 5:10:25 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Chief Executive Officer Derosa Thomas Joseph bought $3,299 worth of shares (10,000 units at $0.33), increasing direct ownership by 22% to 56,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:58:08 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $AACG
    $ABSI
    $ACY
    $AEHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on New York Times with a new price target

    BofA Securities initiated coverage of New York Times with a rating of Neutral and set a new price target of $84.00

    4/22/26 7:57:25 AM ET
    $NYT
    Newspapers/Magazines
    Consumer Discretionary

    Wells Fargo initiated coverage on Cytokinetics with a new price target

    Wells Fargo initiated coverage of Cytokinetics with a rating of Overweight and set a new price target of $95.00

    4/10/26 8:40:13 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wolfe Research initiated coverage on Pharvaris N.V. with a new price target

    Wolfe Research initiated coverage of Pharvaris N.V. with a rating of Outperform and set a new price target of $42.00

    4/9/26 8:43:44 AM ET
    $PHVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AACG
    $ABSI
    $ACY
    $AEHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (NASDAQ:ALGS, "Aligos", "Company")), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company's Board of Directors granted non-qualified stock options to purchase an aggregate of 10,700 shares of the Company's stock (the "Inducement Grant") to newly hired employees on April 22, 2026 (the "Grant Date"), in connection with the commencement of employment. The Inducement Grants were granted pursuant to Aligos' 2024 Inducement Plan (the "Plan") as an induceme

    4/24/26 8:00:00 AM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

    VANCOUVER, Wash. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will report business updates and financial and operating results for the first quarter 2026 after market close on Thursday, May 7, 2026. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company's investor relations website at: investors.absci.com. The

    4/23/26 4:05:00 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Personalis to Announce First Quarter 2026 Financial Results

    Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2026 financial results on Thursday, May 7, 2026. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights. Interested parties may access the call by dialing 877-451-6152 for domestic callers or 201-389-0879 for international callers. The live webinar of the call may be accessed by visiting the Events section of the company's website at investors.personalis.com. A replay of the webinar will be available shortly

    4/23/26 4:01:00 PM ET
    $PSNL
    Medical Specialities
    Health Care

    $AACG
    $ABSI
    $ACY
    $AEHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nerdy Inc.

    SC 13D/A - Nerdy Inc. (0001819404) (Subject)

    12/4/24 4:01:10 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Singular Genomics Systems Inc.

    SC 13D/A - Singular Genomics Systems, Inc. (0001850906) (Subject)

    11/22/24 7:55:51 PM ET
    $OMIC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

    SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

    11/19/24 3:38:53 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $AACG
    $ABSI
    $ACY
    $AEHR
    Financials

    Live finance-specific insights

    View All

    Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

    VANCOUVER, Wash. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will report business updates and financial and operating results for the first quarter 2026 after market close on Thursday, May 7, 2026. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company's investor relations website at: investors.absci.com. The

    4/23/26 4:05:00 PM ET
    $ABSI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Personalis to Announce First Quarter 2026 Financial Results

    Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2026 financial results on Thursday, May 7, 2026. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights. Interested parties may access the call by dialing 877-451-6152 for domestic callers or 201-389-0879 for international callers. The live webinar of the call may be accessed by visiting the Events section of the company's website at investors.personalis.com. A replay of the webinar will be available shortly

    4/23/26 4:01:00 PM ET
    $PSNL
    Medical Specialities
    Health Care

    Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

    HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announced today the initiation of manufacturing activities and technology transfer with SpectronRx under a previously executed Master Services Agreement (MSA), in support of late-stage clinical manufacturing of Rhenium-186 and REYOBIQ. With SpectronRx serving as a second GMP manufacturing site alongside Radiomedix, and Rhenium-186 isotope supplied through Telix Pharmaceuticals, Plus strengthens the reliability of its multi-partner supply chain

    4/23/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $AACG
    $ABSI
    $ACY
    $AEHR
    Leadership Updates

    Live Leadership Updates

    View All

    Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces that it has granted inducement awards to Eric J Daniels, M.D., its new Chief Development Officer who joined the Company on April 20, 2026. The awards were granted on April 20, 2026 under the Company's 2015 New Employee Incentive Plan, as amended, which provides for the granting of equity awards to new employees as an inducement to join the Company. The inducement awards consist of options to purchase 20,000 shares of the Company common

    4/22/26 4:30:00 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors

    MELBOURNE, Australia and SAN FRANCISCO, April 17, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the appointment of Ms Ann Cunningham to its Board of Directors as an independent Non-Executive Director, effective 17th April 2026. Ms Cunningham's appointment further strengthens Alterity's Board composition, adding significant global commercial and strategic expertise as the Company transitions toward late-stage development in Multiple System Atrophy (MSA). Ms Cunningham brings more than 25 years of global pharmac

    4/17/26 7:25:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

    HOUSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announces the appointment of Randy H. Goodman, Ph.D., M.H.A., as Vice President, Value Strategy & Health Economics and Outcomes Research (HEOR), effective April 13th, 2026. Dr. Goodman is a highly experienced health economics and market access leader with more than 20 years of experience spanning global pricing and reimbursement strategy, real-world evidence generation, and value-based healthcare modeling across the biotechnology, pharmaceutic

    4/15/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $AACG
    $ABSI
    $ACY
    $AEHR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care